p53 can suppress inflammatory response by inhibiting NF-kB activity [19] and since it is often mutated by cigarette smoke, oxidant activation of NF-kB may result in a chronic imbalance in COPD and lung cancer. Here, TP53 is linked to lung carcinoma.